JPS5548389A - In vitro cell culturing of hepatitis a virus - Google Patents

In vitro cell culturing of hepatitis a virus

Info

Publication number
JPS5548389A
JPS5548389A JP10364379A JP10364379A JPS5548389A JP S5548389 A JPS5548389 A JP S5548389A JP 10364379 A JP10364379 A JP 10364379A JP 10364379 A JP10364379 A JP 10364379A JP S5548389 A JPS5548389 A JP S5548389A
Authority
JP
Japan
Prior art keywords
hepatitis
virus
cell culture
vitro cell
cell culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10364379A
Other languages
English (en)
Other versions
JPH0157954B2 (ja
Inventor
Jiee Purobuosuto Fuiritsupu
Aaru Hiruman Moorisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5548389A publication Critical patent/JPS5548389A/ja
Publication of JPH0157954B2 publication Critical patent/JPH0157954B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP10364379A 1978-08-17 1979-08-16 In vitro cell culturing of hepatitis a virus Granted JPS5548389A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/934,293 US4164566A (en) 1978-08-17 1978-08-17 Hepatitis a virus cell culture in vitro

Publications (2)

Publication Number Publication Date
JPS5548389A true JPS5548389A (en) 1980-04-07
JPH0157954B2 JPH0157954B2 (ja) 1989-12-08

Family

ID=25465313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10364379A Granted JPS5548389A (en) 1978-08-17 1979-08-16 In vitro cell culturing of hepatitis a virus

Country Status (8)

Country Link
US (1) US4164566A (ja)
EP (1) EP0008559B1 (ja)
JP (1) JPS5548389A (ja)
AT (1) ATE2014T1 (ja)
CA (1) CA1135621A (ja)
DE (1) DE2964276D1 (ja)
DK (1) DK158743C (ja)
IE (1) IE48399B1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5753410A (en) * 1980-07-23 1982-03-30 Merck & Co Inc A type hepatitis virus high value production
JPS5878585A (ja) * 1981-09-09 1983-05-12 ベルトラム・フレ−ミツヒ ヒトの線維芽細胞に適応させたａ型肝炎ウィルス、ａ型肝炎ウィルス抗体を検出する方法及びａ型肝炎ウイルス―ワクチン
JPH01279843A (ja) * 1988-04-28 1989-11-10 Yasuo Moritsugu 凍結乾燥ａ型肝炎ワクチン
JPH01279842A (ja) * 1988-04-28 1989-11-10 Chemo Sero Therapeut Res Inst Ａ型及びｂ型肝炎混合アジュバントワクチン

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PT71739B (en) 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
US4382076A (en) * 1979-11-26 1983-05-03 Merck & Co., Inc. Hepatitis A antibody assay
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4412002A (en) * 1982-02-26 1983-10-25 Merck & Co., Inc. Process for preparing hepatitis A virus
US4894228A (en) * 1982-04-07 1990-01-16 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
USRE37381E1 (en) * 1982-04-07 2001-09-18 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
US4620978A (en) * 1982-04-07 1986-11-04 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis A virus purified and triply cloned
US5478746A (en) * 1982-04-07 1995-12-26 The United States Of America As Represented By The Department Of Health And Human Services cDNA encoding attenuated cell culture adapted hepatitis A virus genome
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
CA1324094C (en) * 1985-04-03 1993-11-09 Dino Dina Hepatitis a virus vaccines
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
JPS63502962A (ja) * 1986-04-01 1988-11-02 ジーンラブズ　インコーポレイテッド ウイルス特異的な永久増殖性組織細胞
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
JPH0751513B2 (ja) * 1988-04-28 1995-06-05 国立予防衛生研究所長 Ａ型肝炎ワクチン
US6117674A (en) * 1988-06-30 2000-09-12 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Pathogen propagation in cultured three-dimensional tissue mass
WO1992019268A1 (en) * 1991-05-08 1992-11-12 Schweiz. Serum- & Impfinstitut Bern New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
US5549896A (en) * 1991-05-08 1996-08-27 Schweiz. Serum- & Impfinstitut Bern Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6190859B1 (en) 1995-04-17 2001-02-20 The United States Of America As Represented By The Secretary Of The Army Method and kit for detection of dengue virus
US6562562B2 (en) * 2000-03-10 2003-05-13 Pharmacia & Upjohn S.P.A. Procedure for partial liver resection in nonhuman primates
EP2686423A4 (en) 2011-03-14 2015-01-28 Nat Res Council Canada METHOD FOR PRODUCING VIRUSES IN CELLS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105011A (en) * 1961-06-19 1963-09-24 Parke Davis & Co Antigens and process of producing same
US3935066A (en) * 1969-07-03 1976-01-27 Burroughs Wellcome Co. Cell lines
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4031203A (en) * 1974-12-09 1977-06-21 Merck & Co., Inc. Hepatitis A antigen
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5753410A (en) * 1980-07-23 1982-03-30 Merck & Co Inc A type hepatitis virus high value production
JPS5878585A (ja) * 1981-09-09 1983-05-12 ベルトラム・フレ−ミツヒ ヒトの線維芽細胞に適応させたａ型肝炎ウィルス、ａ型肝炎ウィルス抗体を検出する方法及びａ型肝炎ウイルス―ワクチン
JPH0571226B2 (ja) * 1981-09-09 1993-10-06 Flehmig Bertram
JPH01279843A (ja) * 1988-04-28 1989-11-10 Yasuo Moritsugu 凍結乾燥ａ型肝炎ワクチン
JPH01279842A (ja) * 1988-04-28 1989-11-10 Chemo Sero Therapeut Res Inst Ａ型及びｂ型肝炎混合アジュバントワクチン

Also Published As

Publication number Publication date
CA1135621A (en) 1982-11-16
DE2964276D1 (en) 1983-01-20
IE48399B1 (en) 1985-01-09
US4164566A (en) 1979-08-14
EP0008559B1 (en) 1982-12-15
JPH0157954B2 (ja) 1989-12-08
DK158743C (da) 1990-12-10
EP0008559A1 (en) 1980-03-05
DK158743B (da) 1990-07-09
IE791575L (en) 1980-02-17
DK343179A (da) 1980-02-18
ATE2014T1 (de) 1982-12-15

Similar Documents

Publication Publication Date Title
JPS5548389A (en) In vitro cell culturing of hepatitis a virus
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
ATE7855T1 (de) Herstellung von virusantigenen.
DK0587873T3 (da) Fremgangsmåde til opnåelse af celler, der er inficeret med en virus, der er forbundet med dissemineret sklerose
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
ES421549A1 (es) Un procedimiento para preparar una vacuna de virus vivos para las vias respiratorias de ganado bovino.
GB1488800A (en) Influenza vaccines
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
DK52783D0 (da) Vaccine indeholdende en ozoninaktiveret mikroorganisme og fremgangsmade til fremstilling af en sadan vaccine
JPS5585390A (en) Promotion of proliferation of bifidobacterium
ATE144429T1 (de) Impfstoff
KR790000405B1 (en) Method of manufacturing influenza vaccines
GB1498821A (en) Vaccines
KR830002512A (ko) 세포 배양액내에서 인플루엔자 왁진의 제조방법
KR870009018A (ko) 단순 포진에 대한 왁진
UA21969A1 (uk) Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі